History

After studies in Mechanical and Environmental Engineering at Bucknell (Lewisburg, PA) and Cornell (Ithaca, NY) Universities, Dr. Aung-Din worked for a period in industry as supervising engineer. He then attended Columbia University in New York City for Premedical studies, followed by Medical School at University of Texas Southwestern Medical School, Dallas, TX. Residencies in Neurology and Neurosurgery followed at University of Florida, Gainesville, FL. Additional studies included a Medical Student Fellowship in Cardiology at Radcliffe Infirmary, Oxford and Clinical Neurology Postgraduate Fellowship at National Hospital for Nervous Disease, Queen Square, London, UK.

Direct Effects

Dr. Aung-Din is also active in treating varied neurological and psychiatric conditions using delivery of CNS-active drugs with Direct Effects topical delivery, a technology developed by him for which 7 patents have been granted to date in the United States, Europe, and Australia; with others filed and pending.

Publications using this novel therapy in migraine, Parkinson’s disease, and diabetic neuropathy appeared in Drug Delivery Technology, Vol.10. No 8, p. 48, October 2010 and Drug Delivery Technology, Vol. 9. No 9, p. 44, October 2009, www.drugdeliverytech.com; and in June 2015 www.drug-dev.com: “THERAPEUTIC FOCUS – Direct Effects(TM) Diabetic Neuropathy Therapy: Treating Symptoms & Modifying Disease.”

Direct Effects topical drug delivery is unique in that therapeutic effect occurs through cutaneous free-nerve endings with direct afferent connections to CNS. As such, general circulation and blood-brain-barrier are bypassed, with avoidance of systemic side effects and drug interactions.